This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Osteoporosis, Sex Hormones and OCPs, Subject name: Pharmacology
Which of the following statements about romosozumab is FALSE? 
Select and explain. 
A. It is a monoclonal antibody against RANK ligand, B. It acts by inhibiting osteoclast, C. It acts by stimulating osteoblast, D. It is indicated in post menopausal osteoporosis
A: It is a monoclonal antibody against RANK ligand
Answer: A: It is a monoclonal antibody against RANK ligand 
Explanation: Romosozumab is a monoclonal antibody against sclerostin. Denosumab is monoclonal antibody against RANK ligand. Romosozumab has dual action in osteoporosis. It stimulates osteoblast as well as inhibits osteoclast. It is used for treatment of post menopausal osteoporosis.